BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Cardiol. Apr 26, 2026; 18(4): 118431
Published online Apr 26, 2026. doi: 10.4330/wjc.v18.i4.118431
Unwanted silent crosstalk: Troponinemia and surgeons
Ayman El-Menyar
Ayman El-Menyar, Department of Surgery, Hamad Medical Corporation, Doha 3050, Qatar
Ayman El-Menyar, Clinical Medicine, Weill Cornell Medicine, Doha 24144, Qatar
Author contributions: El-Menyar A conceptualization, methodology, writing, and review of the manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Corresponding author: Ayman El-Menyar, Department of Surgery, Hamad Medical Corporation, Al-Rayyan Street, Doha 3050, Qatar. aymanco65@yahoo.com
Received: January 4, 2026
Revised: January 8, 2026
Accepted: January 28, 2026
Published online: April 26, 2026
Processing time: 103 Days and 19.3 Hours
Core Tip

Core Tip: The Major non-cardiac surgery is associated with a significant risk of perioperative mortality. This adverse outcome relies mainly on the occurrence of myocardial injury in the perioperative settings. Myocardial injury after non-cardiac surgery remains widely unrecognized, partly because there is no universal consensus on its definition and diagnostic criteria. However, a working diagnosis can be established based on an elevated post-operative cardiac troponin level within 30 days of surgery after excluding other non-ischemic causes, regardless of whether the patient has symptoms or electrocardiogram findings. There is growing consensus for proactive surveillance to mitigate the burden of perioperative cardiovascular complications.

Write to the Help Desk